Utah Retirement Systems’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,658
Closed -$286K 988
2022
Q1
$286K Hold
1,658
﹤0.01% 900
2021
Q4
$268K Hold
1,658
﹤0.01% 938
2021
Q3
$247K Hold
1,658
﹤0.01% 945
2021
Q2
$406K Hold
1,658
0.01% 862
2021
Q1
$439K Hold
1,658
0.01% 839
2020
Q4
$486K Buy
1,658
+258
+18% +$66.2K 0.01% 828
2020
Q3
$331K Buy
1,400
+100
+8% +$22.7K 0.01% 850
2020
Q2
$258K Buy
+1,300
New +$242K ﹤0.01% 915

Other funds holding AMED

Utah Retirement Systems's AMED Position: Q2 2022 in Review

Utah Retirement Systems sold out of Amedisys (AMED) in Q2 2022, closing a stake of 1,658 shares — an estimated $286K sold.

Utah Retirement Systems first reported a position in AMED in Q2 2020 and held it in 8 quarters. The position peaked at $486K in Q4 2020. 288 funds tracked by Wall St. Rank hold AMED as of Q2 2022.

  • Utah Retirement Systems reported no remaining Amedisys position as of Q2 2022 after selling out during the quarter.
  • Utah Retirement Systems sold 1,658 Amedisys shares in Q2 2022, an estimated $286K.
  • Utah Retirement Systems first reported a position in Amedisys in Q2 2020 and held it in 8 quarters.
  • Utah Retirement Systems's Amedisys position peaked at $486K in Q4 2020.
  • 288 funds tracked by Wall St. Rank held Amedisys as of Q2 2022.

Based on Utah Retirement Systems's 13F filing for Q2 2022, filed 16 Aug 2022.